U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07679347) titled 'Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection' on June 17.
Brief Summary: The goal of this clinical trial is to evaluate the safety and performance of the SAVA Continuous Glucose Monitor across glucose ranges over a period of 15-day wear in adults over 18 years of age with Type 1 Diabetes. This is a pilot study, so the main purposes are to collect preliminary data for future studies, assess comfort and safety, and explore the accuracy of the CGM against references and benchmarks.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes Mellitus
...